SHANGHAI PHARM.HLDG H YC1 revenue breakdown overview

SHANGHAI PHARM.HLDG H YC1 revenue for the last year amounted to 33.22 B EUR, the most of which — 29.27 B EUR — came from its highest performing source at the moment, Distribution, the year earlier bringing 27.92 B EUR. The greatest contribution to the revenue figure was made by China — last year it brought SHANGHAI PHARM.HLDG H YC1 32.81 B EUR, and the year before that — 31.77 B EUR.